Who We Are
Delivering on our promise for patients
Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.
We are led by an experienced international management team. Our proprietary product pipeline and next-generation antibody technologies are the result of our strong company culture and a deep passion for innovation. We are inspired by nature and the power of the immune system to transform cancer treatment.
OUR PURPOSE
Combating cancer and other serious diseases through the power of antibodies
Our core purpose summarizes what we strive for – our unstoppable team will improve the lives of patients through innovative and differentiated antibody therapeutics. It supports our vision which captures our aspirations for our future – that by 2030, our knock-your-socks-off “KYSO” antibody medicines are transforming the lives of people with cancer and other serious diseases.
Using science to turn insights into medicine
Genmab is focused on the creation and development of innovative and differentiated antibody products, with the aim of improving the lives of cancer patients. Watch this video to learn more about our core values, products, and track record.
Our core values
In our quest to turn science into medicine, we use these guideposts to transform the future of cancer treatment:
- Passion for innovation
- Determination—being the best at what we do
- Integrity—we do the right thing
- We work as one team and respect each other
Our key accomplishments
Each of our achievements stands as evidence of our unyielding determination, including:
- Creators of multiple marketed products*
- Inventors of four proprietary technologies
- Growing multiple proprietary clinical programs
- Pioneers of a robust pre-clinical pipeline
- World-class leaders with antibody and R&D expertise
- Partners of choice with strategic collaborations
- Solid financials
- Building and expanding our capabilities with more than 1,200 employees across our four international locations
Use our Investor’s Fact Sheet to get a snapshot of our achievements, our process and our financials.
Out-licensed products marketed by partner
Join our mission
Be a part of our team and help transform the future of cancer treatment
Turning insights into medicine
See the results of innovation that is rooted in science
Putting our expertise to work
See how we put our in-depth knowledge of antibody biology into action